What is Evommune 's derecognition upon share buybacks?

Evommune (EVMN) reported derecognition upon share buybacks of -$465.43K in Q1 2026.

How has Evommune 's derecognition upon share buybacks changed year-over-year?

Evommune 's derecognition upon share buybacks decreased by 35.3% year-over-year, from -$343.94K to -$465.43K.

What does derecognition upon share buybacks mean?

Reflects the reduction in derivative liabilities or associated financial obligations resulting from the repurchase of company shares. This metric provides insight into how share buyback programs influence the company's overall liability profile.

Evommune EVMN Derecognition Upon Share Buybacks

Derecognition Upon Share Buybacks at other companies

MBX Biosciences, Inc.MBX

$1K-95.7%

Alumis Inc.ALMS

$94K-84.0%

Diversified Energy DEC

5M+2,875%

ESN

Essent GroupESNT

2.6M-6.8%

WingstopWING

374.3K—

KEE

Keel Infrastructure Corp. Common StockKEEL

-7.8M—

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:DerecognitionUponShareBuybacks.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's derecognition upon share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's derecognition upon share buybacks?: Evommune (EVMN) reported derecognition upon share buybacks of -$465.43K in Q1 2026.
How has Evommune 's derecognition upon share buybacks changed year-over-year?: Evommune 's derecognition upon share buybacks decreased by 35.3% year-over-year, from -$343.94K to -$465.43K.
What does derecognition upon share buybacks mean?: Reflects the reduction in derivative liabilities or associated financial obligations resulting from the repurchase of company shares. This metric provides insight into how share buyback programs influence the company's overall liability profile.